|
Summary Information: Inhibrx Inc. Common Stock NASDAQ:INBX |
  admin@troach.net |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Inhibrx is a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates in oncology and orphan diseases. Inhibrx utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. Inhibrx has collaborations with bluebird bio, Bristol-Myers Squibb and Chiesi.
__The following are links to various summary and news pages for __Inhibrx Inc. Common Stock [ INBX ]. __Note: Some Links might not have information for the company. |
|